These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 182634)

  • 1. Effect of an oral contraceptive on the lysine-8-vasopressin test in the diagnostic evaluation of pituitary function.
    Penttilä IM; Pystynen P; Nummi S
    Horm Metab Res; 1976 Jul; 8(4):299-302. PubMed ID: 182634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype.
    Bertagna X; Coste J; Raux-Demay MC; Letrait M; Strauch G
    J Clin Endocrinol Metab; 1994 Aug; 79(2):390-4. PubMed ID: 8045953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamo-pituitary-adrenal function in pituitary adenoma and craniopharyngioma. Part I: Insulin test, lysine-vasopressin test, and rapid ACTH test.
    Takeuchi J; Sugimoto T; Yoshimi T; Nanno M; Handa H
    Surg Neurol; 1977 Dec; 8(6):423-7. PubMed ID: 202036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.
    Cantalamessa L; Catania A; Baldini M; Orsatti A; Motta P; Peracchi G
    Horm Metab Res; 1990 Jul; 22(7):389-93. PubMed ID: 2169450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
    Hauksson A; Ekström P; Juchnicka E; Laudański T; Akerlund M
    Acta Obstet Gynecol Scand; 1989; 68(1):31-4. PubMed ID: 2801028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human corticotropin-releasing factor plus lysine vasopressin test during glucocorticoid therapy.
    Hashimoto K; Suemaru S; Takao T; Sugawara M; Hattori T; Kageyama J; Takahashi K; Ota Z
    J Clin Invest; 1988 Jul; 82(1):13-6. PubMed ID: 2839544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kinetics of the initial response of plasma corticoids to corticotropin administration].
    Oriol Bosch A; Durán F
    Rev Iber Endocrinol; 1974 May; 21(123):209-15. PubMed ID: 4365976
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of a progestinic-estrogenic combination on human adrenal function.
    Sala G; Castegnaro E
    Res Steroids (Amst); 1966; 2():405-16. PubMed ID: 12305025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man.
    Staub JJ; Jenkins JS; Ratcliffe JG; Landon J
    Br Med J; 1973 Feb; 1(5848):267-9. PubMed ID: 4346579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of diencephalo-hypophysial function in obesity, using the lysine-vasopressin test].
    Scavo D; Giovannini C; Cugini P; Sellini M; Sartori MP
    Folia Endocrinol; 1974 Dec; 27(6pt2):604-13. PubMed ID: 4480658
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of plasma cortisol in the course of testing with lysine-8-vasopressin and with lysine-8-vasopressin + resperine in normal subjects].
    Fierro A; Sellini M; Marchesi L; Massimiani F; Giovannini C
    Boll Soc Ital Biol Sper; 1979 Dec; 55(24):2540-3. PubMed ID: 553570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the pituitary and adrenocortical functions in children with plasma free 11-OHCS as an indicator. II. Pituitary function test using synthesized lysine-8-vasopressin].
    Kawato H
    Nihon Shonika Gakkai Zasshi; 1966 Aug; 70(8):792-806. PubMed ID: 4288854
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes of maternal and fetal pituitary-adrenocortical functions during human labour.
    Vermes I; Kajtár I; Szabó E
    Horm Res; 1979; 11(5):213-7. PubMed ID: 521017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurochemical responses of mice to ACTH and lysine vasopressin.
    Dunn AJ; Iuvone PM; Rees HD
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):139-45. PubMed ID: 13413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free plasma 11-hydroxycorticosteroids and the response to beta1-24-corticotrophin in regular haemodialysis patients.
    Thysell H; Hagstam KE; Lindergård B; Lindholm T
    Scand J Urol Nephrol; 1979; 13(1):95-9. PubMed ID: 217083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.